• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测1岁以下婴儿川崎病静脉注射免疫球蛋白耐药性的新评分系统。

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.

作者信息

Wu Shu, Long Yuan, Chen Selena, Huang Yaqian, Liao Ying, Sun Yan, Zhang Qingyou, Zhang Chunyu, Yan Hui, Qi Jianguang, Liu Xueqin, Chen Yonghong, Zhang Yong, Du Junbao

机构信息

Department of Pediatrics, Peking University First Hospital, Beijing, China.

Research Unit of Clinical Diagnosis and Treatment of Pediatric Syncope and Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Front Pediatr. 2019 Dec 11;7:514. doi: 10.3389/fped.2019.00514. eCollection 2019.

DOI:10.3389/fped.2019.00514
PMID:31921727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6917618/
Abstract

Children with Kawasaki disease (KD) under 1-year old are at high risk for intravenous immunoglobulin (IVIG) resistance. The study was designed to explore the predictive measure of IVIG resistance in infants under 1-year old with KD. This study enrolled children under 1-year old suffering from KD in Peking University First Hospital and Wuhan Children's Hospital. All infants were divided into IVIG-responsive and IVIG-resistant groups. The differences in demographic characteristics, clinical features, and laboratory examinations were compared and the risk factors of IVIG resistant KD were analyzed. Furthermore, a scoring system was developed for predicting IVIG resistance in KD infants and an external validation was performed. A total of 282 infants (194 boys, median age of 7.0 months) were enrolled in this study, of whom 23 children were IVIG-resistant. Compared with IVIG-responsive infants, those in the IVIG-resistant group had a high neutrophil-to-lymphocyte ratio (NLR), high platelet-to-lymphocyte ratio (PLR), high mean platelet volume-to-lymphocyte ratio (MPVLR) in peripheral blood, and low serum albumin, and low serum sodium before IVIG therapy (all < 0.01). Multiple regression analysis indicated that high levels of peripheral NLR and MPVLR, and low levels of serum albumin and serum sodium were independent risk factors for IVIG resistant KD infants. A scoring system, which included peripheral NLR ≥ 2.69 (1 point), MPVLR ≥ 2.78 (1 point), serum albumin ≤ 30.7 g/L (1 point), and serum sodium ≤ 135.2 mmol/L (1 point), was established. A cut-off value of a total score of 2 points or higher yielded a sensitivity of 87.0% and a specificity of 78.4%, with an area under the curve of 0.891. External validation with clinical diagnostic standard showed that a cut-off value of total score of 2 points or higher for predicting the IVIG-resistance yielded a sensitivity of 70.0% and a specificity of 75.1%. For the first time, we proposed a predictive model of IVIG resistance in KD infants under 1-year old. The scoring system, which accounts for baseline peripheral NLR, MPVLR, and serum albumin and sodium, predicts with relatively high sensitivity and specificity for IVIG-resistant infants with KD under 1-year old.

摘要

1岁以下川崎病(KD)患儿发生静脉注射免疫球蛋白(IVIG)抵抗的风险较高。本研究旨在探索1岁以下KD患儿IVIG抵抗的预测指标。本研究纳入了北京大学第一医院和武汉儿童医院的1岁以下KD患儿。所有婴儿被分为IVIG反应型和IVIG抵抗型两组。比较了两组在人口统计学特征、临床特征和实验室检查方面的差异,并分析了IVIG抵抗型KD的危险因素。此外,开发了一种用于预测KD婴儿IVIG抵抗的评分系统,并进行了外部验证。本研究共纳入282例婴儿(194例男孩,中位年龄7.0个月),其中23例为IVIG抵抗型。与IVIG反应型婴儿相比,IVIG抵抗型组婴儿外周血中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、平均血小板体积与淋巴细胞比值(MPVLR)较高,IVIG治疗前血清白蛋白和血清钠水平较低(均P<0.01)。多元回归分析表明,外周血NLR和MPVLR水平较高,血清白蛋白和血清钠水平较低是1岁以下KD患儿IVIG抵抗的独立危险因素。建立了一个评分系统,该系统包括外周血NLR≥2.69(1分)、MPVLR≥2.78(1分)、血清白蛋白≤30.7 g/L(1分)和血清钠≤135.2 mmol/L(1分)。总分2分及以上的截断值产生的灵敏度为87.0%,特异度为78.4%,曲线下面积为0.891。采用临床诊断标准进行外部验证表明,预测IVIG抵抗的总分2分及以上的截断值产生的灵敏度为70.0%,特异度为75.1%。我们首次提出了1岁以下KD患儿IVIG抵抗的预测模型。该评分系统考虑了基线外周血NLR、MPVLR以及血清白蛋白和钠水平,对1岁以下KD IVIG抵抗型婴儿具有较高的预测灵敏度和特异度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c8/6917618/8cb598340381/fped-07-00514-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c8/6917618/d059f9eaac42/fped-07-00514-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c8/6917618/8cb598340381/fped-07-00514-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c8/6917618/d059f9eaac42/fped-07-00514-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c8/6917618/8cb598340381/fped-07-00514-g0002.jpg

相似文献

1
A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.一种用于预测1岁以下婴儿川崎病静脉注射免疫球蛋白耐药性的新评分系统。
Front Pediatr. 2019 Dec 11;7:514. doi: 10.3389/fped.2019.00514. eCollection 2019.
2
Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease.中性粒细胞与淋巴细胞比值可预测12个月以下川崎病婴儿对静脉注射免疫球蛋白的耐药性。
Front Pediatr. 2019 Mar 19;7:81. doi: 10.3389/fped.2019.00081. eCollection 2019.
3
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.预测儿童川崎病的静脉注射免疫球蛋白耐药性。
World J Pediatr. 2020 Dec;16(6):607-613. doi: 10.1007/s12519-020-00348-2. Epub 2020 Mar 30.
4
Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China.静脉注射免疫球蛋白抵抗性川崎病多变量预测评分模型的建立与验证:一项来自中国两个中心的儿童研究
Front Cardiovasc Med. 2022 Apr 27;9:883067. doi: 10.3389/fcvm.2022.883067. eCollection 2022.
5
The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合作为川崎病患者静脉注射免疫球蛋白抵抗的新型预测指标:一项多中心研究
Heart Vessels. 2020 Oct;35(10):1463-1472. doi: 10.1007/s00380-020-01622-z. Epub 2020 May 24.
6
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
7
[Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].[静脉注射免疫球蛋白抵抗型川崎病患儿血清白细胞介素-17A的表达及其临床意义]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):244-249. doi: 10.7499/j.issn.1008-8830.2210151.
8
Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.C反应蛋白/白蛋白比值在预测静脉注射免疫球蛋白抵抗性川崎病中的价值——来自中国多机构研究的数据
Int Immunopharmacol. 2020 Dec;89(Pt A):107037. doi: 10.1016/j.intimp.2020.107037. Epub 2020 Nov 23.
9
Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.治疗前后川崎病患者静脉注射免疫球蛋白抵抗和冠状动脉瘤的实验室预测因子评估。
Clin Rheumatol. 2023 Jan;42(1):167-177. doi: 10.1007/s10067-022-06366-x. Epub 2022 Sep 21.
10
[Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease].[外周血淋巴细胞亚群对静脉注射免疫球蛋白抵抗型川崎病患儿的预测价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1211-1218. doi: 10.7499/j.issn.1008-8830.2305067.

引用本文的文献

1
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.营养相关生物标志物在预测川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变中的作用:一项系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan.
2
Role of Pyroptosis in IVIG-Resistant Kawasaki Disease and the Establishment of a New Predictive Model.细胞焦亡在静脉注射免疫球蛋白抵抗性川崎病中的作用及新预测模型的建立
J Inflamm Res. 2024 Dec 13;17:10999-11008. doi: 10.2147/JIR.S490095. eCollection 2024.
3
The Central Role of Interleukin-1 Signalling in the Pathogenesis of Kawasaki Disease Vasculitis: Path to Translation.

本文引用的文献

1
Kawasaki disease: origins and evolution.川崎病:起源与演变
Arch Dis Child. 2021 Apr;106(4):413-414. doi: 10.1136/archdischild-2019-317070. Epub 2019 Oct 18.
2
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.2013 年至 2017 年上海川崎病的流行病学特征。
J Epidemiol. 2020 Oct 5;30(10):429-435. doi: 10.2188/jea.JE20190065. Epub 2019 Sep 21.
3
Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions.平均血小板体积(MPV):炎症病程和预后标志物的新视角。
白细胞介素-1信号在川崎病血管炎发病机制中的核心作用:转化之路
Can J Cardiol. 2024 Dec;40(12):2305-2320. doi: 10.1016/j.cjca.2024.07.023. Epub 2024 Jul 30.
4
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
5
Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.川崎病静脉注射免疫球蛋白抵抗风险预测模型:使用 PROBAST 进行风险评估。
Pediatr Res. 2023 Sep;94(3):1125-1135. doi: 10.1038/s41390-023-02558-6. Epub 2023 Mar 24.
6
Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis.血液炎症标志物对预测川崎病静脉注射免疫球蛋白抵抗的价值:一项系统评价和荟萃分析。
Front Pediatr. 2022 Aug 23;10:969502. doi: 10.3389/fped.2022.969502. eCollection 2022.
7
Mean platelet volume to lymphocyte ratio and platelet distribution width to lymphocyte ratio in Iraqi patients diagnosed with systemic lupus erythematosus.伊拉克系统性红斑狼疮确诊患者的平均血小板体积与淋巴细胞比率及血小板分布宽度与淋巴细胞比率
Reumatologia. 2022;60(3):173-182. doi: 10.5114/reum.2022.117837. Epub 2022 Jul 13.
8
[Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].[川崎病治疗前发热持续时间与静脉注射免疫球蛋白抵抗之间的关联]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Apr 15;24(4):399-404. doi: 10.7499/j.issn.1008-8830.2110137.
9
Complement 3 and the Prognostic Nutritional Index Distinguish Kawasaki Disease from Other Fever Illness with a Nomogram.补体3与预后营养指数通过列线图鉴别川崎病与其他发热性疾病。
Children (Basel). 2021 Sep 20;8(9):825. doi: 10.3390/children8090825.
10
Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.川崎病患者血清钠水平与冠状动脉病变的相关性
Clin Rheumatol. 2022 Jan;41(1):137-145. doi: 10.1007/s10067-021-05881-7. Epub 2021 Aug 7.
Mediators Inflamm. 2019 Apr 17;2019:9213074. doi: 10.1155/2019/9213074. eCollection 2019.
4
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.川崎病患儿对静脉注射免疫球蛋白无反应风险较高者,采用免疫球蛋白加环孢素进行初级治疗预防冠状动脉异常的疗效(KAICA):一项随机对照、开放标签、盲终点、3 期临床试验。
Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7.
5
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases.血小板与淋巴细胞比值作为风湿性疾病的炎症标志物。
Ann Lab Med. 2019 Jul;39(4):345-357. doi: 10.3343/alm.2019.39.4.345.
6
Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.2015 - 2016年日本川崎病全国流行病学调查
Pediatr Int. 2019 Apr;61(4):397-403. doi: 10.1111/ped.13809. Epub 2019 Apr 16.
7
A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients.重庆预测静脉注射免疫球蛋白抵抗川崎病的新模型:5277 例患者的回顾性研究。
Sci Rep. 2019 Feb 11;9(1):1722. doi: 10.1038/s41598-019-39330-y.
8
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.白细胞介素-6 易于成为预测川崎病不完全反应和免疫球蛋白静脉注射无反应的候选生物标志物,而非冠状动脉瘤。
Clin Exp Med. 2019 May;19(2):173-181. doi: 10.1007/s10238-018-00544-5. Epub 2019 Jan 8.
9
A new scoring system to predict Kawasaki disease with coronary artery lesions.一种新的评分系统,用于预测伴有冠状动脉损伤的川崎病。
Clin Rheumatol. 2019 Apr;38(4):1099-1107. doi: 10.1007/s10067-018-4393-7. Epub 2018 Dec 6.
10
Hyponatremia in children with respiratory infections: a cross-sectional analysis of a cohort of 3938 patients.儿童呼吸道感染并发低钠血症:3938 例患者队列的横断面分析。
Sci Rep. 2018 Nov 7;8(1):16494. doi: 10.1038/s41598-018-34703-1.